
Akon-CV - 325 Tablet
Marketer
Accosts Remedies Pvt Ltd
Salt Composition
Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)
Overview Akon-CV - 325 Tablet
Combivir-325 tablets contain a dual-action formula indicated for respiratory infections. This prescription medication combats existing infection and inhibits further microbial proliferation. Always adhere to your physician's prescribed dosage; while food is optional, consistent timing is crucial for optimal results. Exceeding the recommended dose can be detrimental. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor the medication's effects.
Uses of Akon-CV - 325 Tablet
Managing infections of the airways
Major Benefits of Akon-CV - 325 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Akon-CV 325 Tablets. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. These tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Akon-CV - 325 Tablet:
- Nausea
- Diarrhea
- Headache
- Rash
- Abdominal pain
- Vaginal infection
- Fungal infection of vagina
How to use Akon-CV - 325 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Akon-CV 325 Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets can be administered with or without food, however, consistent timing is recommended.
How Akon-CV - 325 Tablet works:
Akon-CV 325 tablets contain Cefpodoxime Proxetil, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefpodoxime Proxetil's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Clavulanic Acid counteracts bacterial resistance mechanisms, thereby boosting Cefpodoxime Proxetil's effectiveness.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Akon-CV - 325 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Akon-CV - 325 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Akon-CV 325 mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no apparent harm to the infant.
DrivingUNSAFE
Driving ability may be impaired by Akon-CV 325 Tablet side effects, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Akon-CV 325 mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Akon-CV - 325 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Akon-CV - 325 Tablet :
Should you forget to take your Akon-CV 325 Tablet, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Akon-CV - 325 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
